NorthboundBio

Leuven ·KBO/BCE: BE 1008.524.836

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	28-05-2026	64 d early	2026-00131135
31-12-2024	31-07-2025	28-05-2025	64 d early	2025-00113098

Metric	This company	Sector median	Position in the sector
Solvency	79.0%	53.8%	better than 77% of 56 sector peers
Net result	€141k	€24k	better than 93% of 56 sector peers
Equity	€227k	€50k	better than 86% of 56 sector peers
Gross operating margin	€182k	€49k	better than 90% of 56 sector peers
Total assets	€287k	€158k	better than 78% of 56 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€287k
Fixed assets	21/28	€35k
Financial fixed assets	28	€35k
Current assets	29/58	€251k
Amounts receivable within one year	40/41	€424
Cash & bank	54/58	€232k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€287k
Equity	10/15	€227k
Contributions / capital	10/11	€3k
Reserves	13	€224k
Amounts payable	17/49	€60k
Amounts payable within one year	42/48	€60k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€182k
Operating result	9901	€181k
Financial income	75	€230
Financial charges	65	€128
Result before taxes	9903	€182k
Income taxes	67/77	€40k
Net result for the period	9904	€141k
Result to be appropriated	9905	€141k

Summary